Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Innoviva (INVA) over the last 17 years, with Q3 2025 value amounting to $21.6 million.

  • Innoviva's Accumulated Expenses rose 2277.4% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.6 million, marking a year-over-year increase of 2277.4%. This contributed to the annual value of $30.0 million for FY2024, which is 5229.46% up from last year.
  • According to the latest figures from Q3 2025, Innoviva's Accumulated Expenses is $21.6 million, which was up 2277.4% from $38.0 million recorded in Q2 2025.
  • Over the past 5 years, Innoviva's Accumulated Expenses peaked at $38.0 million during Q2 2025, and registered a low of $1.7 million during Q1 2021.
  • Its 5-year average for Accumulated Expenses is $11.2 million, with a median of $5.2 million in 2023.
  • As far as peak fluctuations go, Innoviva's Accumulated Expenses tumbled by 2019.16% in 2023, and later surged by 79608.42% in 2025.
  • Over the past 5 years, Innoviva's Accumulated Expenses (Quarter) stood at $4.2 million in 2021, then soared by 93.21% to $8.0 million in 2022, then soared by 145.55% to $19.7 million in 2023, then skyrocketed by 52.29% to $30.0 million in 2024, then decreased by 27.97% to $21.6 million in 2025.
  • Its Accumulated Expenses stands at $21.6 million for Q3 2025, versus $38.0 million for Q2 2025 and $30.7 million for Q1 2025.